Alexander E. Zambidis

Alexander E. Zambidis

Auto-generated profile, based on publicly available information

Alexander E. Zambidis

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AZAlexander E. Zambidis
Alexander E. Zambidis
LSLatha Kallur Siddaramaiah
Latha Kallur Siddaramaiah
AKAndrew J. Konecny
Andrew J. Konecny
MGMatthew Gray
Matthew Gray
MPMartin Prlic
Martin Prlic
Summary: Accurate spectral unmixing is a critical step for flow cytometry data analysis and requires a single stain control for every fluorescent parameter used in an experiment. Currently, compensation particles are often used for making single stain controls when a target protein is of low abundance or a cell type is of low frequency. However, compensation particles introduce incongruencies in emission spectra compared to cells resulting in spectral unmixing or compensation errors. To enable the use of cells regardless of the abundance of target proteins or immune cell type, we generated a bispecific antibody that links a human anti-CD45 and mouse anti-IgG variable region. We refer to this new bispecific tool as CaptureBody (CB) and highlight the benefits of its final nanobody-based design. We provide all sequences and methods necessary for the in-house expression of a CaptureBody to disseminate their use for spectral flow cytometry experiments.

1 November 2024 in Connected Science Learning
Verified
Journal Article
Open access
JSJessica L. Stellmann
Jessica L. Stellmann
AZAlexander E. Zambidis
Alexander E. Zambidis
AMAdam L. MacLean
Adam L. MacLean
DKDieuwertje J. Kast
Dieuwertje J. Kast